A peptide is a short chain of amino acids linked together by chemical bonds called peptide bonds.

The body uses 20 different amino acids to build them.

The difference between a peptide and a protein is size. Peptides are typically fewer than 50 amino acids long. Proteins are longer.

Cells release peptides into the bloodstream and tissues to send messages. These messages do three things.

• Regulate metabolism. Insulin tells cells to take in glucose. Glucagon tells the liver to release glucose. GLP-1 slows digestion and increases insulin secretion.
• Manage pain and mood. Endorphins reduce pain and create feelings of well-being. Substance P carries pain signals. Oxytocin and vasopressin regulate social bonding and memory.
• Coordinate immune defense and repair. Antimicrobial peptides kill bacteria and fungi. Growth factors trigger tissue repair. Cytokines coordinate immune responses to infection.

A peptide is how the body sends a message from one cell to another. Change the sequence, change the message.

Peptide signals are how the body coordinates itself.

They work three ways:

• Over distance, through the bloodstream.
• Between neurons, in the nervous system.
• Locally, in tissues.

A single peptide signal can have multiple effects in different tissues, because tissues can express different versions of the same receptor.

Distance signals: hormones. When blood glucose rises after eating, the pancreatic beta cells release insulin.

Insulin travels through the bloodstream to muscle, liver, and fat cells. They respond by taking in glucose.

When glucose drops between meals, the alpha cells release glucagon, which tells the liver to release stored glucose. Both are peptide hormones coordinating whole-body metabolism.

Local signals: neuropeptides and cytokines. In the gut, when food arrives, enteroendocrine cells release dozens of peptide signals: GLP-1, GLP-2, CCK, PYY.

These work on nerve endings to signal satiety to the brain, and directly on the pancreas to regulate insulin. A single peptide can trigger different effects depending on which tissue it acts on.

Defense and repair. When the body is wounded, immune cells release peptides that kill bacteria and fungi, attract more immune cells, and trigger inflammation.

At the same time, growth factor peptides like FGF and VEGF recruit blood vessels and fibroblasts to rebuild the tissue. Multiple peptide signals coordinate offense and repair simultaneously.

Without peptide signals, there is no hunger, no satiety, no immune response, no healing.

Sequence determines shape. Shape determines which receptor fits. The receptor determines what the peptide does in the body.

Change one amino acid, and you can change or destroy the signal.

Insulin is a 51-amino-acid peptide. The first six are Phe-Val-Asn-Gln-His-Leu.

Those six residues and the next forty-five create a specific three-dimensional shape that fits insulin receptors on muscle, liver, and fat cells.

Change even one amino acid, and the shape changes. The signal may be weaker, stronger, or absent entirely.

20 building blocks. Thousands of different peptides. Same alphabet, different words.

The body uses the same 20 amino acids to make insulin, glucagon, GLP-1, endorphins, growth factors, and immune peptides.

Each performs a completely different job because of the order in which the amino acids are arranged.

Semaglutide is a modified GLP-1 peptide. It keeps the same receptor-recognized signal shape, but specific amino acid substitutions and a C-18 fatty acid chain change how long it lasts.

Those changes help semaglutide last about seven days in the bloodstream instead of minutes.

Same signal, same receptor fit, dramatically different duration.

Receptors are proteins, on the surface of cells or inside them, that wait for a matching signal.

The peptide's shape must fit the receptor's shape, like a key in a lock.

When the key fits and turns the lock, the cell changes its behavior.

When insulin is released from the pancreas, it floats through the bloodstream until it encounters an insulin receptor on a muscle, liver, or fat cell.

The insulin peptide fits into a groove in the receptor. The binding changes the shape of the receptor, which triggers a chain reaction inside the cell.

Signaling proteins activate. Genes turn on or off. The cell begins taking in glucose.

Same signal. Same receptor fit. Three different outcomes.

Not all cells respond the same way to the same signal.

Muscle cells take in glucose and burn it for energy.

Liver cells take in glucose and store it as glycogen.

Fat cells take in glucose and store it as fat.

The difference is in what genes each cell type has turned on or off.

Some receptors are G-protein coupled receptors. Others are receptor tyrosine kinases. They work through different pathways.

But the mechanism is always the same: peptide shape matches receptor shape, binding occurs, cell behavior changes.

Evolution has had 500 million years to modify peptide signals.

Yet many haven't changed at all.

Human insulin and rat insulin are nearly identical. Fruit flies and mammals use nearly the same growth factors and immune peptides.

Some of the deepest evolutionary conservation in biology is in peptide signaling.

This happens when a peptide signal solves a fundamental survival problem so well that any change makes it worse.

Insulin regulates glucose in organisms from bacteria to humans. The amino acid sequence that lets insulin bind to its receptor was already optimal 500 million years ago.

A mutation that changed the sequence would either do nothing or break the signal. Natural selection keeps removing organisms that break insulin.

The sequence stays locked in place.

The same is true for endorphins, growth factors, and many immune peptides. These aren't cosmetic features. They're core mechanisms.

A small change in sequence can mean the difference between life and death.

If a signal has worked in nature for 500 million years, it's likely to be safe.

That's why insulin derived from pig and cow pancreases worked as the first peptide medicine. Their insulin is nearly identical to human insulin.

The body recognizes them.

The pathway from peptide signal to peptide drug has the same steps every time.

Identification. Scientists notice a clinical pattern, then look for the missing signal.

Diabetic patients had high blood glucose and low insulin. Researchers identified insulin as the missing signal.

Obese people had low satiety signals. Researchers discovered leptin.

People with poor wound healing had low growth factors. Researchers found FGF, VEGF, and IGF-1.

Understanding. Once a signal is identified, researchers study what it does.

They map which tissues have receptors for it. They measure how long it lasts in the bloodstream. They discover side effects and off-target effects.

Stabilization and delivery. Natural peptides are fragile. They last minutes to hours in the bloodstream before enzymes break them down.

To make them useful as medicine, scientists modify the peptide. They change amino acids, or attach it to other molecules.

Then they need a way to deliver it.

Insulin was the first success. Frederick Banting and Charles Best discovered insulin in 1921.

They had no way to synthesize it. They extracted it from cow and pig pancreases.

It worked. Millions of diabetics went from death to life.

Today, human insulin is made by genetically engineering bacteria to produce it.

GLP-1 is a 30-amino-acid peptide released by enteroendocrine cells in the small intestine after a meal.

It is one signal in a symphony of signals the body uses to manage eating and metabolism.

What GLP-1 does. It acts on three main targets.

When the body eats, GLP-1 travels through the bloodstream to the pancreas, the stomach, and the brain.

At the pancreas, it increases insulin secretion. At the stomach, it slows gastric emptying. In the brain, it increases satiety and reduces hunger.

GLP-1 also affects glucose sensing, reward pathways, and immune cells.

A single 30-amino-acid peptide does dozens of things.

GLP-1 is not unique. At the same time the intestine releases GLP-1, it releases GLP-2, CCK, PYY, oxyntomodulin, and dozens of others.

Each has overlapping and distinct effects. They work together to coordinate digestion, nutrient absorption, metabolic rate, and satiety signals to the brain.

Context matters. The effect of GLP-1 depends on what else is happening.

If the body has just eaten a meal high in fat, GLP-1 slows the stomach more.

If the body is fasting and blood glucose is low, GLP-1 doesn't stimulate insulin as much.

If cortisol is high under stress, GLP-1's effects on reward and hunger are different.

Peptide signals are not isolated switches. They're integrated into a system.

Semaglutide works because it activates the same GLP-1 receptors as the natural signal.

By lasting seven days instead of two minutes, it creates sustained satiety and improved glucose control.

The same peptide signal, just given a longer lifespan.

Dorothy Hodgkin won the Nobel Prize in Chemistry for determining the structure of vitamin B12.

Her work on peptide and protein structure showed that the sequence of amino acids determines three-dimensional shape. Shape determines function.

This insight launched modern peptide medicine.

Sequence determines structure. The amino acids in a peptide don't exist in a straight line. They fold, twist, and bond with each other.

Hydrophobic amino acids cluster together, away from water. Hydrophilic amino acids face outward. Charged amino acids attract or repel each other.

All these forces together create a specific 3D shape.

Structure determines binding. The receptor doesn't count amino acids. It reads the 3D shape.

If you change the position of even one amino acid in a way that distorts the overall shape, the peptide may not fit into its receptor anymore.

The signal fails.

Modifications preserve structure while changing duration. When researchers modified GLP-1 to create semaglutide, they didn't randomly change amino acids.

They changed specific positions in ways that preserved the overall shape, so it still fits the GLP-1 receptor.

At the same time, the changes added resistance to the enzymes that normally break down GLP-1.

Same shape. Same receptor fit. Thousands of times longer in circulation.

Understanding peptide structure is also how researchers design entirely new peptides.

They can take a proven peptide signal, modify it to hit a different receptor or last longer or work in a different tissue, and create a new therapeutic.

All based on the principle that sequence creates structure, and structure creates function.